Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

LUNGevity Foundation

Lungevity Foundation logo

Spring 2025
By Stephanie Lowitt

With grants totaling $400,000 from LUNGevity Foundation, Jaclyn LoPiccolo, MD, PhD, is researching prediction of genetic lung cancer risk in people under 45 and how risk factors may guide screening and therapeutic approaches; and Elliot Brea, MD, PhD, is exploring how a modified CAR T-cell therapy may be effective in treating non-small cell lung cancer.

, ,
Copy link
Powered by Social Snap